指南与共识老年慢病共病管理多重用药

老年住院COPD患者:吸入支气管扩张剂与糖皮质激素的国际指南依从性

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.
指南 / 共识 · J Am Med Dir Assoc · 2019-03-07

研究基于REPOSI前瞻性多中心注册登记,纳入2008至2016年≥65岁住院患者,分析COPD患病率及对GOLD指南的依从性。结果显示COPD患者占21.5%,入院和出院时指南依从率分别为34.3%和35.6%,依从性与全因死亡风险降低相关。

要点

  • 住院老年患者中COPD患病率为21.5%,常伴功能状态受损和多病共存。
  • COPD患者入院和出院时GOLD指南依从率仅34.3%和35.6%。
  • 指南依从性与全因死亡风险降低独立相关(OR 0.12,95%CI 0.02-0.90)。

核心结论

  • 老年急性住院患者中COPD常见且功能临床状态较差,处方常不遵循GOLD指南,依从性差与更差临床状态相关。

研究设计与样本

  • REPOSI前瞻性多中心观察性注册登记,纳入2008至2016年≥65岁住院患者,共6046例,其中COPD患者1302例。

主要发现

  • COPD患者入院时GOLD指南依从率为34.3%,出院时为35.6%。
  • 入院时多重用药(≥5种药物)与指南依从性相关(OR 3.28,95%CI 2.24-4.81)。
  • 入院时有急性COPD加重史与指南依从性相关(OR 2.65,95%CI 1.44-4.88)。
  • 吸烟习惯与指南依从性相关(OR 1.45,95%CI 1.08-1.94)。
  • 出院时多重用药与指南依从性相关(OR 6.76,95%CI 4.15-11.0)。

关键数值与推荐

  • 指南依从性定义为入院和出院时吸入支气管扩张剂和糖皮质激素处方符合2018年GOLD指南。
  • 指南依从性与全因死亡发生呈负相关(OR 0.12,95%CI 0.02-0.90)。
  • COPD与心血管和呼吸系统死亡及再住院风险独立相关。

临床怎么用

  • 老年住院COPD患者应评估吸入支气管扩张剂和糖皮质激素处方是否符合GOLD指南。
  • 关注多重用药、吸烟史和急性加重史等与指南依从性相关的临床因素。
  • 提高指南依从性可能有助于降低全因死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to analyze the prevalence and impact of COPD in older patients hospitalized in internal medicine or geriatric wards, and to investigate adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, associated clinical factors, and outcomes. DESIGN: Data were obtained from REgistro POliterapie SIMI (REPOSI), a prospective multicenter observational registry that enrolls inpatients aged ≥65 years. SETTING AND PARTICIPANTS: Older hospitalized patients enrolled from 2008 to 2016 with a diagnosis of COPD. MEASURES: We evaluated adherence to the 2018 GOLD guidelines at admission and discharge, by examining the prescription of inhaled bronchodilators and corticosteroids in COPD patients. We also evaluated the occurrence of outcomes and its association with COPD and guideline adherence. RESULTS: At hospital admission, COPD was diagnosed in 1302 (21.5%) of 6046 registered patients. COPD patients were older, with more impaired clinical and functional status and multiple comorbidities. Overall, 34.3% of COPD patients at admission and 35.6% at discharge were adherent to the GOLD guidelines. Polypharmacy (≥5 drugs) at admission [odds ratio (OR): 3.28, 95% confidence interval (CI): 2.24-4.81], a history of acute COPD exacerbation (OR: 2.65, 95% CI: 1.44-4.88) at admission, smoking habit (OR: 1.45, 95% CI: 1.08-1.94), and polypharmacy at discharge (OR: 6.76, 95% CI: 4.15-11.0) were associated with adherence to guidelines. COPD was independently associated with the risk of cardiovascular and respiratory death and rehospitalization occurrence compared to patients without COPD during follow-up. Adherence to guidelines was inversely associated with the occurrence of death from all causes (OR: 0.12, 95% CI: 0.02-0.90). CONCLUSIONS/IMPLICATIONS: COPD was common in older patients acutely hospitalized, showing an impaired functional and clinical status. Prescriptions for older COPD patients were often not adherent to GOLD guidelines. Poor adherence to guidelines was associated with a worse clinical status. There is a need to improve adherence to guidelines in treating COPD patients, with the ultimate goal of reducing clinical events.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Proietti M, Agosti P, Lonati C, et al. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. J Am Med Dir Assoc. 2019. PMID: 30852169. doi:10.1016/j.jamda.2019.01.132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。